Health Care & Life Sciences » Biotechnology | Theratechnologies Inc.

Theratechnologies Inc. | Ownership

Companies that own Theratechnologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Stewardship Partners Investment Counsel, Inc.
6,176,340
9.36%
478,705
100%
12/31/2017
The Caisse de dépôt et placement du Québec
4,313,700
6.54%
-950,000
0.04%
12/31/2017
Artisan Partners LP
1,122,094
1.7%
451,400
0.01%
06/30/2018
O'Shaughnessy Asset Management LLC
780,081
1.18%
-116,510
0.11%
12/31/2017
Dimensional Fund Advisors LP
499,856
0.76%
-125,800
0%
04/30/2018
Desjardins Global Asset Management, Inc.
156,967
0.24%
3,784
0.02%
04/30/2018
Mawer Investment Management Ltd.
120,000
0.18%
-450,000
0%
12/31/2017
BlackRock Asset Management Canada Ltd.
78,190
0.12%
0
0%
09/06/2018
Fisher Asset Management LLC
76,083
0.12%
38,410
0%
06/30/2018
Industrial Alliance Investment Management, Inc.
74,800
0.11%
74,800
0.01%
08/31/2018

About Theratechnologies

View Profile
Address
2015 Peel Street
Montréal Québec H3A 1T8
Canada
Employees -
Website http://www.theratech.com
Updated 07/08/2019
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). It offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.